Learn about the World Molecular Diagnostics Market

Market Wire, June, 2008

Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue.

World Molecular Diagnostics Market

http://www.reportlinker.com/p090566/World-Molecular-Diagnostics-Market.html

This report analyzes the worldwide markets for Molecular Diagnostics in Millions of US$. The specific product segments analyzed are Infectious Disease Testing, Pharmacogenomics, and Cancer Screening. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 103 companies including many key and niche players worldwide such as Abbott Laboratories, Abbott Molecular, Applera Corporation, Celera, Biomerieux, CytoCore Inc., GE Healthcare, Gen-Probe Inc., Genzyme Corporation, Genzyme Genetics, MiraiBio, Inc., Nanogen, Novartis Vaccines & Diagnostics, Inc., QIAGEN N. V, Digene Corporation, Quest Diagnostics Incorporated, Roche Diagnostics, Siemens Healthcare Diagnostics, and Tecan Group Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

MOLECULAR DIAGNOSTICS MCP-1226

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

Infectious Diseases Testing I-3

Pharmacogenomics I-4

Cancer Screening I-4

II. EXECUTIVE SUMMARY

1. Industry Overview II-1

Global Market Outlook II-1

Molecular Diagnostics - The Fastest Growing Medical

Diagnostic Technology II-1

New Applications Hold Promising Potential II-1

Automated Systems - Prime Target II-2

Infectious Disease Testing Drives the Diagnostics Market II-2

The Future in Store II-3

2. A Review of Medical Diagnostics Market II-4

Clinical Diagnostics Industry - Trends and Tendencies II-4

Table 1: Worldwide In Vitro Diagnostics (IVD) Market (2005 &

2006)- Percentage Breakdown by Value Sales for

Immunochemistry, Diabetes, Clinical Chemistry, Point-of-care

testing, Molecular Diagnostics, Hematology, Coagulation,

Urinalysis, and Others (includes corresponding Graph/Chart) II-5

Table 2: Leading Players in the Worldwide In Vitro

Diagnostics (IVD) Market (2005) - Percentage Breakdown by

Value Sales for Roche Diagnostics, Abbott Laboratories,

Johnson & Johnson, Bayer Diagnostics, Beckman Coulter, Dade

Behring, and Others (includes corresponding Graph/Chart) II-5

Table 3: Leading Players in the Worldwide Molecular

Diagnostics Market (2006) - Percentage Breakdown by Value

Sales for Roche Diagnostics, Chiron, Bayer Diagnostics,

GenProbe, Abbott Laboratories, Becton Dickinson, and Others

(includes corresponding Graph/Chart) II-6

Diagnostic Tests - Classification II-6

Table 4: Leading Players in the Worldwide Genetic Testing

Market (2006) - Percentage Breakdown by Value Sales for Roche

Diagnostics /Affymetrix, Abbott Laboratories, Bio-Rad

Laboratories, and Others(includes corresponding Graph/Chart) II-7

Nucleic Acid Diagnostics Market - An Overview II-7

Molecular Diagnostics - Growth Drivers II-8

Molecular Diagnostics - A Replacement and Enabling Technology II-9

Molecular Diagnostics for Lymphoid Malignancies II-9

3. Competitive Dynamics in the Molecular Diagnostics Market II-10

Key Players and Their Technologies II-10

The Top Tier II-10

Mid-Sized and Small Companies II-10

4. Market Trends & Issues II-12

Market Consolidations on the Way to Integrate in Vivo andin

Vitro Diagnostics II-12

Global Molecular Diagnostics on High Growth Curve II-12

Pharmaceutical Firms Carving Their Niche in Molecular

Diagnostic Market II-12

Towards Tailoring the Right Treatment for the Right Disease II-12

Disease-Specific Molecular Diagnostics to Deliver Improved

Clinical Outcomes II-13

Molecular Diagnostics and Intellectual Property II-13

Business Opportunities in the Offing II-13

Challenges Facing the Molecular Diagnostic Market II-14

Medical Training and Practice Challenges II-14

Shortcomings to Overcome II-14

Limited Reimbursements by Third Party Payers - A Stumbling Block II-15

Hurdles All the Way for Companies Eyeing Molecular Diagnostics II-15

Product Marketing - Key to Commercial Success II-16

Integration of Molecular Diagnostics into Therapeutics II-16

Molecular Diagnostics - Moving from Centralization to

Decentralization II-17

Migrating to Decentralized Format II-17

Going Ahead with Decentralization II-17

5. Product & Technology Overview II-19

Molecular Diagnostics - Definition & Scope II-19

Molecular Diagnostics - Impact on Healthcare II-19

Utility of Molecular Diagnostic Tests II-20

Background of Molecular Diagnostics II-20

Major Molecular Diagnostics Company Products II-20

Major Test Launches in Molecular Diagnostics II-21

Unabated Developments in Molecular Diagnostics Technology II-21

Signal Amplification Technologies II-21

PCR - New Developments II-21